[Baricitinib (rheumatoid arthritis) - Addendum to commission A17-14]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003307
German
Original Title:
Baricitinib (rheumatoide Arthritis) - Addendum zum Auftrag A17-14
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a17-36.html
Year Published:
2017
URL for published report:
https://www.iqwig.de/download/A17-36_Baricitinib_Addendum-zum-Auftrag-A17-14_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Arthritis, Rheumatoid
- Janus Kinase Inhibitors
- Antirheumatic Agents
- Azetidines
- Pyrazoles
- Purines
- Sulfonamides
Keywords
- Baricitinib
- Arthritis - Rheumatoid
- Benefit Assessment
- NCT01710358
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.